Mbeneumologia.org

Noviembre 2007. Cáncer de Pulmón
14…WOK
Clinical trial monitoring method for e.g. respiratory flow meter, involves transmitting script program to
remotely situated apparatus e.g. interactive television system, through communication network e.g.
internet. Brown, S. J.
(US2007168242-A1)
116.EMBASE
Comparative study of clinical application value with CT-Orientator stereotactic percutaneous puncture
biopsy for pulmonary masses. [Chinese]. Wang,B., Wen,Z.-Q., Wu,X.-J., Wen,Y.-M., and Shen,Z.-X.
Journal of Interventional.Radiology.16.(8.)(pp.557.-560.), 2007.Date.of Publication.: Aug.2007.Aug
117.EMBASE
CT guided fine needle aspiration cytology of thoracic mass lesions: A prospective study of immediate
cytological evaluation. Bandyopadhyay,A., Laha,R., Das,T.K., Sen,S., Mangal,S., and Mitra,P.K.
Indian Journal of Pathology and Microbiology.50.(1)(pp.51.-55.), 2007.Date.of Publication.: Jan.2007.Jan
118.EMBASE
Patient education in COPD during inpatient rehabilitation improves quality of life and morbidity.
[German]. Wittmann,M., Spohn,S., Schultz,K., Pfeifer,M., and Petro,W.
Pneumologie.61.(10)(pp.636.-643.), 2007.Date.of Publication.: Oct.2007.Oct
119.EMBASE
Salmeterol/fluticasone propionate: A review of its use in the treatment of chronic obstructive pulmonary
disease. Keating,G.M. and McCormack,P.L.
Drugs.67.(16.)(pp.2383.-2405.), 2007.Date.of Publication.: 2007.2007
120.EMBASE
Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease.
Wu,T.-C., Huang,Y.-C., Hsu,S.-Y., Wang,Y.-C., and Yen,S.-L.
International.Journal for.Vitamin.and Nutrition Research.77.(4)(pp.272.-279.), 2007.Date.of Publication.:
Jul.2007.Jul
121.EMBASE
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease
severity: A systematic review and meta-analysis. Gosker,H.R., Zeegers,M.P., Wouters,E.F.M., and
Schols,A.M.W.J.
Thorax.62.(11)(pp.944.-949.), 2007.Date.of Publication.: Nov.2007.Nov
122.EMBASE
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: A randomised controlled
trial. Bourbeau,J., Christodoulopoulos,P., Maltais,F., Yamauchi,Y., Olivenstein,R., and Hamid,Q.
Thorax.62.(11)(pp.938.-943.), 2007.Date.of Publication.: Nov.2007.Nov
123.EMBASE
Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive
pulmonary disease: Systematic review and meta-analysis. Coventry,P.A. and Hind,D.
Journal of Psychosomatic.Research.63.(5)(pp.551.-565.), 2007.Date.of Publication.: Nov.2007.Nov
124.EMBASE
Chronic Obstructive Pulmonary Disease in the Older Patient. Nazir,S.A., Al-Hamed,M.M., and Erbland,M.L.
Clinics.in Chest Medicine.28.(4)(pp.703.-715.), 2007.Date.of Publication.: Dec.2007.Dec
125.EMBASE
The effect of computer reminders on GPs' prescribing behaviour: A cluster-randomised trial.
Martens,J.D., van der,W.T., Severens,J.L., de Clercq,P.A., de Bruijn,D.P., Kester,A.D.M., and Winkens,R.A.G.
International.Journal of Medical.Informatics.76.(SUPPL.3)(pp.S403.-S416.), 2007.Date.of Publication.:
Dec.2007.Dec
126.EMBASE
Short-term and long-term outcomes of moxifloxacin treatment in acute exacerbations of COPD.
[Chinese]. Zhang,M., Zhou,X., Zhang,X.-Y., and Ding,X.
Chinese.Journal of Infection and Chemotherapy.7.(5)(pp.313.-317.), 2007.Date.of Publication.:
Oct.2007.Oct
127.EMBASE
Qualitative outcomes of progressive resistance exercise for people with COPD. O'Shea,S.D., Taylor,N.F.,
and Paratz,J.D.
Chronic.Respiratory.Disease.4(3)(pp.135.-142.), 2007.Date.of Publication.: 2007.2007
128.EMBASE
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and
budesonide/formoterol DPI in asthma. Morice,A.H., Peterson,S., Beckman,O., and Osmanliev,D.
International.Journal of Clinical.Practice.61.(11)(pp.1874.-1883), 2007.Date.of Publication.: Nov.2007.Nov
129.EMBASE
The nonpharmacologic treatment of chronic obstructive pulmonary disease: Advances in our
understanding of pulmonary rehabilitation. ZuWallack,R.
Proceedings.of the American Thoracic.Society.4(7.)(pp.549.-553.), 2007.Date.of Publication.:
Oct.2007.Oct
130.EMBASE
Inhaled corticosteroids in chronic obstructive pulmonary disease. Suissa,S., McGhan,R., Niewoehner,D.,
and Make,B.
Proceedings.of the American Thoracic.Society.4(7.)(pp.535.-542.), 2007.Date.of Publication.:
Oct.2007.Oct
131.EMBASE
Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease. Kanat,F.,
Vatansev,H., and Teke,T.
Netherlands Journal of Medicine.65.(8.)(pp.296.-300.), 2007.Date.of Publication.: Sep.2007.Sep
132.EMBASE
Psychometric properties of the WHODASII in rehabilitation patients. Posl,M., Cieza,A., and Stucki,G.
Quality.of Life Research.16.(9.)(pp.1521.-1531.), 2007.Date.of Publication.: Nov.2007.Nov
133.EMBASE
A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation.
Hachem,R.R., Yusen,R.D., Chakinala,M.M., Meyers,B.F., Lynch,J.P., Aloush,A.A., Patterson,G.A., and
Trulock,E.P.
Journal of Heart and Lung Transplantation.26.(10)(pp.1012.-1018.), 2007.Date.of Publication.:
Oct.2007.Oct
134.EMBASE
Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Neder,J.A.,
Fuld,J.P., Overend,T., Thirlwell,J., Carter,R., Stevenson,R., and Ward,S.A.
Respiratory.Medicine.101.(10)(pp.2056.-2064.), 2007.Date.of Publication.: Oct.2007.Oct
135.EMBASE
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta₂-agonist, in patients
with COPD: A 28-day randomised, placebo controlled clinical trial . Beier,J., Chanez,P., Martinot,J.-B.,
Schreurs,A.J.M., Tkacova,R., Bao,W., Jack,D., and Higgins,M.
Pulmonary Pharmacology and Therapeutics.20.(6.)(pp.740.-749.), 2007.Date.of Publication.:
Dec.2007.Dec
136.EMBASE
Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal
beta₂-agonist. Akamatsu,K., Yamagata,T., Takahashi,T., Miura,K., Maeda,S., Yamagata,Y.,
Ichikawa,T., Yanagisawa,S., Ueshima,K., Hirano,T., Nakanishi,M., Matsunaga,K., Minakata,Y., and Ichinose,M.
Pulmonary Pharmacology and Therapeutics.20.(6.)(pp.701.-707.), 2007.Date.of Publication.:
Dec.2007.Dec
137.EMBASE
Depressed and anxious COPD patients: Predictors of psychotherapy engagement from a clinical trial.
Cully,J.A., Graham,D.P., Stanley,M.A., and Kunik,M.E.
Journal of Clinical.Psychology.in Medical.Settings.14(2)(pp.160.-164.), 2007.Date.of Publication.:
Jun.2007.Jun
138.EMBASE
Adherence to a home-walking prescription in patients with chronic obstructive pulmonary disease.
Donesky-Cuenco,D., Janson,S., Neuhaus,J., Neilands,T.B., and Carrieri-Kohlman,V.
Heart and Lung: Journal of Acute.and Critical Care.36.(5)(pp.348.-363.), 2007.Date.of Publication.:
Sep.2007.Journal-363
139.EMBASE
Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD. Derom,E.,
Strandgarden,K., Schelfhout,V., Borgstrom,L., and Pauwels,R.
Respiratory.Medicine.101.(9.)(pp.1931.-1941.), 2007.Date.of Publication.: Sep.2007.Sep
140.EMBASE
Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators
for severe and very severe COPD patients. Dal,N.R., Eandi,M., Pradelli,L., and Iannazzo,S.
International.Journal of COPD.2(2)(pp.169.-176.), 2007.Date.of Publication.: 2007.2007
141.EMBASE
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled
corticosteroids. Hodder,R., Kesten,S., Menjoge,S., and Viel,K.
International.Journal of COPD.2(2)(pp.157.-167.), 2007.Date.of Publication.: 2007.2007
142.EMBASE
On the correct statistical analysis of exacerbation rates in clinical trials [5]. Suissa,S.
American Journal of Respiratory.and Critical Care Medicine.176.(5)(pp.522.), 2007.Date.of Publication.:
01.Sep.2007.01
143.EMBASE
Investigating new standards for prophylaxis in reduction of exacerbations - The INSPIRE study
methodology. Seemungal,T., Stockley,R., Calverley,P., Hagan,G., and Wedzicha,J.A.
COPD.: Journal of Chronic.Obstructive.Pulmonary Disease.4(3)(pp.177.-183.), 2007.Date.of Publication.:
Sep.2007.Journal-183
144.EMBASE
Effects of tiotropium combined with either salmeterol or salmeterol/fluticasone in moderate to severe
COPD. Kaplan,A.
Primary.Care Respiratory.Journal.16.(4)(pp.258.-260.), 2007.Date.of Publication.: Aug.2007.Aug
145.EMBASE
Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with
transient exertional hypoxemia. Nonoyama,M.L., Brooks,D., Guyatt,G.H., and Goldstein,R.S.
American Journal of Respiratory.and Critical Care Medicine.176.(4)(pp.343.-349.), 2007.Date.of
Publication.: 15.Aug.2007.15
146.EMBASE
Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Kolodziej,M.A.,
Jensen,L., Rowe,B., and Sin,D.
European.Respiratory.Journal.30.(2)(pp.293.-306.), 2007.Date.of Publication.: Aug.2007.Aug
147.EMBASE
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A systematic review with
meta-analysis. Rodrigo,G.J. and Nannini,L.J.
Pulmonary Pharmacology and Therapeutics.20.(5)(pp.495.-502.), 2007.Date.of Publication.: Oct.2007.Oct
148.EMBASE
Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients
after participation? Karapolat,H., Atasever,A., Atamaz,F., Kirazli,Y., Elmas,F., and Erdinc,E.
Lung.185.(4)(pp.221.-225.), 2007.Date.of Publication.: Aug.2007.Aug
149.EMBASE
The clinical management in extremely severe COPD. Ambrosino,N. and Simonds,A.
Respiratory.Medicine.101.(8.)(pp.1613.-1624.), 2007.Date.of Publication.: Aug.2007.Aug
150.EMBASE
Bronchodilators in COPD: Impact of beta-agonists and anticholinergics on severe exacerbations and
mortality. Salpeter,S.R.
International.Journal of COPD.2(1)(pp.11-18.), 2007.Date.of Publication.: 2007.2007
151.EMBASE
Effects of an integrated care intervention on risk factors of COPD readmission. Garcia-Aymerich,J.,
Hernandez,C., Alonso,A., Casas,A., Rodriguez-Roisin,R., Anto,J.M., and Roca,J.
Respiratory.Medicine.101.(7.)(pp.1462.-1469.), 2007.Date.of Publication.: Jul.2007.Jul
152.EMBASE
New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
Spruit,M.A. and Wouters,E.F.M.
Sports Medicine.37.(6.)(pp.501.-518.), 2007.Date.of Publication.: 2007.2007
153.EMBASE
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of
chronic obstructive pulmonary disease in Spain. Rutten-Van Molken,M.P.M.H., Oostenbrink,J.B.,
Miravitlles,M., and Monz,B.U.
European.Journal of Health Economics.8.(2)(pp.123.-135.), 2007.Date.of Publication.: Jun.2007.Jun
154.EMBASE
Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. Oba,Y.
Mayo Clinic.Proceedings.82.(5)(pp.575.-582.), 2007.Date.of Publication.: May.2007.May
Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression.
Wolfe,K.J., Wickliffe,J.K., Hill,C.E., Paolini,M., Ammenheuser,M.M., and bdel-Rahman,S.Z.
Pharmacogenetics and Genomics 2007; 17:897-905.
CCC:000250476300001
[Quantitative methylation-specific PCR for the diagnosis of lung cancer]. Grote,H.J., Schmiemann,V.,
Kazimirek,M., and Bocking,A.
Pathologe 2007; 28:
MEDLINE:17665199
Intersession reproducibility of mass spectrometry profiles and its effect on accuracy of multivariate
classification models. Pelikan,R., Bigbee,W.L., Malehorn,D., Lyons-Weiler,J., and Hauskrecht,M.
Bioinformatics 2007; 23:
MEDLINE:17766268
Associations between Beer, Wine, and Liquor Consumption and Lung Cancer Risk: A Meta-analysis.
Chao,C.
Cancer Epidemiol Biomarkers Prev 2007; 16:
MEDLINE:18006934
Family History of Cancer and Risk of Lung Cancer among Nonsmoking Chinese Women. Zhang,Y.,
Shu,X.O., Gao,Y.T., Ji,B.T., Yang,G., Li,H.L., Kilfoy,B., Rothman,N., Zheng,W., and Chow,W.H.
Cancer Epidemiol Biomarkers Prev 2007; 16:
MEDLINE:18006933
Bronchial epithelial ki-67 index is related to histology, smoking, and gender, but not lung cancer or
chronic obstructive pulmonary disease. Miller,Y.E., Blatchford,P., Hyun,D.S., Keith,R.L., Kennedy,T.C.,
Wolf,H., Byers,T., Bunn,P.A.J., Lewis,M.T., Franklin,W.A., Hirsch,F.R., and Kittelson,J.
Cancer Epidemiol Biomarkers Prev 2007; 16:
MEDLINE:18006932
Combined Prognostic Value of Both RelA and IkappaB-alpha Expression in Human Non-Small Cell Lung
Cancer. Zhang,D., Jin,X., Wang,F., Wang,S., Deng,C., Gao,Z., and Guo,C.
Ann Surg Oncol 2007; 14:
MEDLINE:17899287
Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum
and a nested case-control study for risk assessment. Hsu,H.S., Chen,T.P., Wen,C.K., Hung,C.H.,
Chen,C.Y., Chen,J.T., and Wang,Y.C.
J Pathol 2007; 213:
MEDLINE:17973238
Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis
of nonsmall cell lung cancer. Hoagland,L.F.M., Campa,M.J., Gottlin,E.B., Herndon,J.E., and Patz,E.F.J.
Cancer 2007; 110:
MEDLINE:17918261
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.
Hittelman,W.N., Liu,D.D., Kurie,J.M., Lotan,R., Lee,J.S., Khuri,F., Ibarguen,H., Morice,R.C., Walsh,G.,
Roth,J.A., Minna,J., Ro,J.Y., Broxson,A., Hong,W.K., and Lee,J.J.
J Natl Cancer Inst 2007; 99:
MEDLINE:17971525
Ensemble methods for classification of patients for personalized medicine with high-dimensional data.
Moon,H., Ahn,H., Kodell,R.L., Baek,S., Lin,C.J., and Chen,J.J.
Artif Intell Med 2007; 41:
MEDLINE:17719213
The impact of genetic markers on the diagnosis of lung cancer: a current perspective. Chorostowska-
Wynimko,J. and Szpechcinski,A.
J Thorac Oncol 2007; 2:
MEDLINE:17975498
Detection of lung cancer by automated sputum cytometry. Kemp,R.A., Reinders,D.M., and Turic,B.
J Thorac Oncol 2007; 2:
MEDLINE:17975489
Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non
Small Cell Lung Cancer. Loprevite,M., Tiseo,M., Chiaramondia,M., Capelletti,M., Bozzetti,C., Bortesi,B.,
Naldi,N., Nizzoli,R., Dadati,P., Kunkl,A., Zennaro,D., Lagrasta,C., Campanini,N., Spiritelli,E., Camisa,R.,
Grossi,F., Rindi,G., Franciosi,V., and Ardizzoni,A.
Clin Cancer Res 2007; 13:
MEDLINE:17975165
Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar
epithelium identifies candidate biomarkers. Chatterji,B. and Borlak,J.
Proteomics 2007; 7:
MEDLINE:17902193
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal
growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Mitsudomi,T. and Yatabe,Y.
Cancer Sci 2007; 98:
MEDLINE:17888036
Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic
target for lung cancer. Mano,Y., Takahashi,K., Ishikawa,N., Takano,A., Yasui,W., Inai,K., Nishimura,H.,
Tsuchiya,E., Nakamura,Y., and Daigo,Y.
Cancer Sci 2007; 98:
MEDLINE:17888034
Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in
plasma. Hsu,H.S., Chen,T.P., Hung,C.H., Wen,C.K., Lin,R.K., Lee,H.C., and Wang,Y.C.
Cancer 2007; 110:
MEDLINE:17876837
Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway
mediating tumor necrosis factor-alpha signaling. Zer,C., Sachs,G., and Shin,J.M.
Physiol Genomics 2007; 31:
MEDLINE:17652167
S-adenosylmethionine as a biomarker for the early detection of lung cancer. Greenberg,A.K., Rimal,B.,
Felner,K., Zafar,S., Hung,J., Eylers,E., Phalan,B., Zhang,M., Goldberg,J.D., Crawford,B., Rom,W.N.,
Naidich,D., and Merali,S.
Chest 2007; 132:
MEDLINE:17934114
Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a
population of Northern Spain. Lopez-Cima,M.F., Gonzalez-Arriaga,P., Garcia-Castro,L., Pascual,T.,
Marron,M.G., Puente,X.S., and Tardon,A.
BMC Cancer 2007; 7:
MEDLINE:17705814
An electronic nose in the discrimination of patients with asthma and controls. Dragonieri,S., Schot,R.,
Mertens,B.J.A., Le Cessie,S., Gauw,S.A., Spanevello,A., Resta,O., Willard,N.P., Vink,T.J., Rabe,K.F., Bel,E.H.,
and Sterk,P.J.
J Allergy Clin Immunol 2007; 120:
MEDLINE:17658592
Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old.
Vineis,P. and Perera,F.
Cancer Epidemiol Biomarkers Prev 2007; 16:
MEDLINE:17932342
Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Tsao,S.M., Yin,M.C.,
and Liu,W.H.
Nutr Cancer 2007; 59:
MEDLINE:17927496
Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and
neuroendocrine tumors: expression and survival analysis. Shilo,K., Dracheva,T., Mani,H., Fukuoka,J.,
Sesterhenn,I.A., Chu,W.S., Shih,J.H., Jen,J., Travis,W.D., and Franks,T.J.
Arch Pathol Lab Med 2007; 131:
MEDLINE:17922592
Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific
polymerase chain reaction for tumour suppressor genes including RUNX3. Tan,S.H., Ida,H., Lau,Q.C.,
Goh,B.C., Chieng,W.S., Loh,M., and Ito,Y.
Oncol Rep 2007; 18:
MEDLINE:17914577
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Yildiz,P.B., Shyr,Y., Rahman,J.S.M., Wardwell,N.R., Zimmerman,L.J., Shakhtour,B., Gray,W.H., Chen,S., Li,M.,
Roder,H., Liebler,D.C., Bigbee,W.L., Siegfried,J.M., Weissfeld,J.L., Gonzalez,A.L., Ninan,M., Johnson,D.H.,
Carbone,D.P., Caprioli,R.M., and Massion,P.P.
J Thorac Oncol 2007; 2:
MEDLINE:17909350
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth
factor receptor tyrosine kinase inhibitors. Noro,R., Gemma,A., Miyanaga,A., Kosaihira,S., Minegishi,Y.,
Nara,M., Kokubo,Y., Seike,M., Kataoka,K., Matsuda,K., Okano,T., Yoshimura,A., and Kudoh,S.
Int J Oncol 2007; 31:
MEDLINE:17912443
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients
with advanced cancer. Hsu,D.S., Balakumaran,B.S., Acharya,C.R., Vlahovic,V., Walters,K.S., Garman,K.,
Anders,C., Riedel,R.F., Lancaster,J., Harpole,D., Dressman,H.K., Nevins,J.R., Febbo,P.G., and Potti,A.
J Clin Oncol 2007; 25:
MEDLINE:17906199
Positron emission tomography imaging as a cancer biomarker. Yu,E.Y. and Mankoff,D.A.
Expert Rev Mol Diagn 2007; 7:
MEDLINE:17892371
Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung
cancer. Helmig,S. and Schneider,J.
Expert Rev Mol Diagn 2007; 7:
MEDLINE:17892364
CpG islands: their potential as biomarkers for cancer. Shi,H., Wang,M.X., and Caldwell,C.W.
Expert Rev Mol Diagn 2007; 7:
MEDLINE:17892361
Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Qi,W., Liu,X.,
Chen,W., Li,Q., and Martinez,J.D.
Mol Carcinog 2007; 46:
MEDLINE:17394238
PIK3CA gene amplification in Japanese non-small cell lung cancer. Kawano,O., Sasaki,H., Okuda,K.,
Yukiue,H., Yokoyama,T., Yano,M., and Fujii,Y.
Lung Cancer 2007; 58:
MEDLINE:17681398
Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction
marker in surgically resected non-small cell lung cancers. Yanagawa,N., Tamura,G., Oizumi,H.,
Kanauchi,N., Endoh,M., Sadahiro,M., and Motoyama,T.
Lung Cancer 2007; 58:
MEDLINE:17606310
The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3
correlated with different subtypes of non-small cell lung cancers. Oh,J.J., Koegel,A.K., Phan,D.T.,
Razfar,A., and Slamon,D.J.
Lung Cancer 2007; 58:
MEDLINE:17606309

Source: http://www.mbeneumologia.org/mbe/docsMBE/pdf/80_CB.pdf